Amersham Pharmacia Biotech to supply Progenesis™

Amersham Pharmacia Biotech to supply Progenesis™ - Nonlinear Dynamics' high-throughput image analysis software for Proteomics research

(Newcastle upon Tyne, UK and Piscataway, NJ, USA). Nonlinear Dynamics Ltd, a leading provider of bioinformatics solutions, announces that Amersham Pharmacia Biotech (APBiotech) has signed a non-exclusive distributor agreement for sales of Nonlinear's Progenesis™ 2D electrophoresis image analysis software.

Progenesis is a "hands-free" automated image analysis system specifically designed for researchers using 2D gel electrophoresis for their high-throughput proteomics projects. By automating the analysis stage of 2D gel electrophoresis, Progenesis has smashed the bottleneck traditionally associated with this widely used and effective method for protein expression studies. Progenesis complements and supports APBiotech's Ettan™ proteomics research platform.

Will Dracup, Managing Director and founder of Nonlinear Dynamics, said: "We already have an extremely good working relationship with Amersham Pharmacia Biotech since they sell our standard products under the ImageMaster™ name." He added, "This new venture drives our collaboration forward to a new phase, allowing us to utilise our combined expertise and respond to the demanding needs of the proteomics market place."

Neil Cook, Vice President of Drug Discovery, APBiotech, said: "With more than 40 years of experience in the protein sciences, APBiotech has built a portfolio of technologies specifically for high-throughput proteomics, and Progenesis is an excellent addition to that portfolio."

About Amersham Biosciences

Amersham Biosciences, the life sciences business of Amersham plc (LSE: NYSE: OSE: AHM), is a world leader in developing and providing integrated systems and solutions for disease research, drug development and manufacture. Its systems are used to uncover the function of genes and proteins, for the discovery and development of drugs and for the manufacture of biopharmaceuticals. The customers for Amersham Biosciences' products and technologies are pharmaceutical and biotechnology companies and research and academic institutions, principally in North America, Europe, Latin America and Asia. More information about Amersham Biosciences is available at www.amershambiosciences.com.

About Nonlinear Dynamics Ltd

Established in 1989, Nonlinear Dynamics is a leading worldwide provider of bioinformatics solutions to the life science industry. The Company's innovative product portfolio comprises high-quality analysis and data mining tools for 1D and 2D electrophoresis gels and microarrays, the core technologies of genomics and proteomics. Nonlinear sells and supports its products through its UK headquarters, its USA office, and its global network of partners and OEMs.

Contact us for more information, or contact our Marketing Department directly.
Released: 31 July 2001

Current press releases | Archive press releases